We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Rapid-Live Screening Microscopy Technique Enables Early Detection of Treatment-Resistant Cancer Cells

By LabMedica International staff writers
Posted on 27 Sep 2023
Print article
Image: A new microscopy method detects treatment-resistant cancer cells early (Photo courtesy of 123RF)
Image: A new microscopy method detects treatment-resistant cancer cells early (Photo courtesy of 123RF)

Chemotherapy serves as an effective tool in the fight against cancer, yet some cancer cells can evade treatment by going into a dormant state known as senescence. These so-called therapy-induced senescent (TIS) cells can become not just resistant to treatment but also potentially more harmful, even metastasizing. Early identification of TIS cells could be crucial in stopping their progression, but current detection techniques aren't quick or accurate enough. Now, new advanced microscopy techniques may offer a solution, allowing healthcare providers to identify these cells early on and adapt treatment plans accordingly.

A team of researchers at Johns Hopkins University (Baltimore, MD, USA) used a combination of three state-of-the-art, label-free microscopy methods—coherent Raman scattering, multi-photon absorption, and optical diffraction tomography—to examine TIS cells in their natural setting. This approach is unlike traditional methods and gave the scientists the ability to look at the cells' form, internal structure, and both physical and chemical properties during their entire life cycle.

The use of these advanced microscopy methods uncovered significant transformations within the TIS cells. For instance, within a day, the cells' mitochondria—the "energy factories" inside them—had repositioned themselves. By the 72-hour mark, the cells had started to excessively produce fatty molecules known as lipids and had become flatter and larger. This in-depth analysis helped the researchers establish a detailed timeline of these cellular changes. According to the team, their novel rapid-live screening microscopy methods offer great potential for advancing cancer research.

"Our work demonstrates the potential to transform anticancer treatment research," said Ishan Barman, an associate professor of mechanical engineering at Johns Hopkins Whiting School of Engineering. "Integrating these microscopy methods could help clinicians make more informed, timely treatment decisions."

Related Links:
Johns Hopkins University 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.